SARS-CoV-2 vaccine strategies in kidney transplant recipients
Authors:
- 27 October 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 23 (3) , 263-264
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation—A Danish nationwide cohort studyAmerican Journal of Transplantation, 2022
- Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipientsAmerican Journal of Transplantation, 2022
- Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipientsJCI Insight, 2022
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19New England Journal of Medicine, 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Cell, 2022
- Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant RecipientsJAMA Internal Medicine, 2021
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant RecipientsNew England Journal of Medicine, 2021
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccinationNature Medicine, 2021
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicine, 2020